The concept of high-frequency electric stimulation in the brain (deep brain stimulation [DBS]) to alleviate a variety of neurologic and psychiatric, otherwise therapy-refractory disorders has gained wide acceptance. DBS continuously delivers electrical pulses, variable in amplitude, pulse width, and frequency, through permanently implanted electrodes, which are connected to an internal pulse generator. The electrodes are placed by using stereotactic methods based on imaging protocols (CT, MR imaging) combined with real-time intraoperative x-ray and electrophysiology. Depending on the diagnosis and patient-specific symptoms, different anatomic targets have been proposed. Currently DBS is performed with the patient awake, to assess the effectiveness and the side effect spectrum of stimulation.
Although progress has been made in understanding the optimal anatomic structures as target areas for DBS, little effort has been put into modeling and predicting electromagnetic field properties of activated DBS electrodes and understanding their interactions with the adjacent tissue. Those targets have been empirically well-defined and proven to be beneficial in alleviating the neurologic and/or psychiatric symptoms, but the true mechanism of DBS is still poorly understood.
Recent advances in the development of key technologies like optogenetic neuromodulation (an experimental technique used in animals to differentially influence neuronal tissues on the basis of genetic